 Home > Active Ingredient News > Blood System > Blood: CBRN multiple mutations associated with multiple myeloma and drug resistance to lysamine or pomadamine.

Blood: CBRN multiple mutations associated with multiple myeloma and drug resistance to lysamine or pomadamine.

 Last Update: 2020-09-01
 Source: Internet
 Author: User

Tags

cancer drug resistance

which describes protein

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The emergence of resistance to all available treatments is a major challenge in improving survival in myeloma patients.
Cereblon (CRBN) is a widely used IMiD and new CellMOD drug for myeloma and an essential binding protein for certain PROTACs that are being developed for a variety of diseases. Using genome-wide sequencing data from 455 patients and RNA sequencing data from 655 patients,
found that the frequency of three CRBN variants (i.e., point mutations, missing copies/structural variations, and special transcript variations (e.g., exogenation 10 shear variations)) increased gradually, with sexual exposure of IMiD until approximately one-third of the progressions were CBRN variants in patients where POM was difficult to treat.
the researchers found that all three CRBN variants were associated with poor POM treatment in patients with LEN incurable patients, including individuals who had not previously studied the number of copies they carried and structural variations.
it is understood that this study is the first comprehensive analysis of CBRN variation in patients with myeloma who are progressing in treatment, which can help guide patients to choose the sequence therapy of CRBN-targeted drugs.
.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

SULODEXIDE 99% Almost White Powder Dideu-01112 Dideu

CAS No.: 57821-29-1

Pharmacy Grade

$61.76/G EXW

Heparin sodium 9041-08-1 vials safe delivery

CAS No.: 9041-08-1

Pharmacy Grade

$1/G EXW

Gadusol Powder Gadusol76663-30-4

CAS No.: 76663-30-4

Industrial Grade

$1-1.01/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.